Katharina Mascherbauer, Carolina Donà, Matthias Koschutnik, Varius Dannenberg, Christian Nitsche, Franz Duca, Gregor Heitzinger, Kseniya Halavina, Eva Steinacher, Christina Kronberger, Constanze Bardach, Dietrich Beitzke, Christian Loewe, Elisabeth Waldmann, Michael Trauner, Philipp Barkto, Georg Goliasch, Julia Mascherbauer, Christian Hengstenberg, Andreas Kammerlander
BACKGROUND: Liver damage is frequently observed in patients with cardiovascular disease but infrequently quantified. We hypothesized that in patients with cardiovascular disease undergoing cardiac magnetic resonance, liver T1-times indicate liver damage and are associated with cardiovascular outcome. METHODS: We measured hepatic T1-times, displayed on standard cardiac T1-maps, in an all-comer cardiac magnetic resonance-cohort. At the time of cardiac magnetic resonance, we assessed validated general liver fibrosis scores...
October 2022: Circulation. Cardiovascular Imaging